Cargando…
Thrombotic Thrombocytopenia Masquerading As COVID-19 Infection
Thrombotic thrombocytopenic purpura (TTP) is a rare and challenging diagnosis that consists of thrombotic microangiopathy due to complete or severe deficiency of ADAMTS13 protease that can present at any age. It is very important to have a suspicion concerning this disease as mortality can be very h...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379868/ https://www.ncbi.nlm.nih.gov/pubmed/35989804 http://dx.doi.org/10.7759/cureus.26933 |
_version_ | 1784768758507634688 |
---|---|
author | Desai, Krishna Sridhar, Aarthi Matos, Jose Mulla, Sana Thirumaran, Rajesh |
author_facet | Desai, Krishna Sridhar, Aarthi Matos, Jose Mulla, Sana Thirumaran, Rajesh |
author_sort | Desai, Krishna |
collection | PubMed |
description | Thrombotic thrombocytopenic purpura (TTP) is a rare and challenging diagnosis that consists of thrombotic microangiopathy due to complete or severe deficiency of ADAMTS13 protease that can present at any age. It is very important to have a suspicion concerning this disease as mortality can be very high if it goes unnoticed. This case describes a patient that presented with gastrointestinal symptoms and hematuria and was found to have COVID-19 and TTP. We present a case of a 40-year-old female with no past medical history who presented to the Emergency Department with complaints of abdominal pain, nausea, vomiting, and dark urine. The patient workup revealed a platelet count of 4000. The patient was also noted to be COVID-19 positive. Upon further workup, the TTP diagnosis was confirmed. She responded appropriately to plasmapheresis and steroids. COVID-19 seems to be linked to a wide range of hematologic conditions including but not limited to TTP. In view that TTP can have significant mortality if untreated, we must be suspicious about this condition in COVID-19 cases. The aim of this case report is to highlight the importance of having a low threshold for making a diagnosis of TTP if labs are significant for hemolytic anemia. Our aim is also to emphasize that the treatment should be initiated if schistocytes are seen on the peripheral smear without awaiting laboratory results confirming low levels of ADAMTS13, given the fatal nature of the condition if left untreated. |
format | Online Article Text |
id | pubmed-9379868 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-93798682022-08-18 Thrombotic Thrombocytopenia Masquerading As COVID-19 Infection Desai, Krishna Sridhar, Aarthi Matos, Jose Mulla, Sana Thirumaran, Rajesh Cureus Internal Medicine Thrombotic thrombocytopenic purpura (TTP) is a rare and challenging diagnosis that consists of thrombotic microangiopathy due to complete or severe deficiency of ADAMTS13 protease that can present at any age. It is very important to have a suspicion concerning this disease as mortality can be very high if it goes unnoticed. This case describes a patient that presented with gastrointestinal symptoms and hematuria and was found to have COVID-19 and TTP. We present a case of a 40-year-old female with no past medical history who presented to the Emergency Department with complaints of abdominal pain, nausea, vomiting, and dark urine. The patient workup revealed a platelet count of 4000. The patient was also noted to be COVID-19 positive. Upon further workup, the TTP diagnosis was confirmed. She responded appropriately to plasmapheresis and steroids. COVID-19 seems to be linked to a wide range of hematologic conditions including but not limited to TTP. In view that TTP can have significant mortality if untreated, we must be suspicious about this condition in COVID-19 cases. The aim of this case report is to highlight the importance of having a low threshold for making a diagnosis of TTP if labs are significant for hemolytic anemia. Our aim is also to emphasize that the treatment should be initiated if schistocytes are seen on the peripheral smear without awaiting laboratory results confirming low levels of ADAMTS13, given the fatal nature of the condition if left untreated. Cureus 2022-07-17 /pmc/articles/PMC9379868/ /pubmed/35989804 http://dx.doi.org/10.7759/cureus.26933 Text en Copyright © 2022, Desai et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Desai, Krishna Sridhar, Aarthi Matos, Jose Mulla, Sana Thirumaran, Rajesh Thrombotic Thrombocytopenia Masquerading As COVID-19 Infection |
title | Thrombotic Thrombocytopenia Masquerading As COVID-19 Infection |
title_full | Thrombotic Thrombocytopenia Masquerading As COVID-19 Infection |
title_fullStr | Thrombotic Thrombocytopenia Masquerading As COVID-19 Infection |
title_full_unstemmed | Thrombotic Thrombocytopenia Masquerading As COVID-19 Infection |
title_short | Thrombotic Thrombocytopenia Masquerading As COVID-19 Infection |
title_sort | thrombotic thrombocytopenia masquerading as covid-19 infection |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379868/ https://www.ncbi.nlm.nih.gov/pubmed/35989804 http://dx.doi.org/10.7759/cureus.26933 |
work_keys_str_mv | AT desaikrishna thromboticthrombocytopeniamasqueradingascovid19infection AT sridharaarthi thromboticthrombocytopeniamasqueradingascovid19infection AT matosjose thromboticthrombocytopeniamasqueradingascovid19infection AT mullasana thromboticthrombocytopeniamasqueradingascovid19infection AT thirumaranrajesh thromboticthrombocytopeniamasqueradingascovid19infection |